According to GlaxoSmithKline Pharmaceuticals latest financial reports the company has an operating margin of 0.23%, an increase of 7.96% to 2022. At the end of 2022 company had an operating margin of 0.21%.
Year | Operating Margin | Change |
---|---|---|
2023 | 0.23% | 7.96% |
2022 | 0.21% | 12.50% |
2021 | 0.19% | 27.47% |
2020 | 0.15% | - |